Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 558

1.

Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor neovasculature.

Yu DH, Lu Q, Xie J, Fang C, Chen HZ.

Biomaterials. 2010 Mar;31(8):2278-92. doi: 10.1016/j.biomaterials.2009.11.047. Epub 2010 Jan 6.

PMID:
20053444
2.

Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.

Bai F, Wang C, Lu Q, Zhao M, Ban FQ, Yu DH, Guan YY, Luan X, Liu YR, Chen HZ, Fang C.

Biomaterials. 2013 Aug;34(26):6163-74. doi: 10.1016/j.biomaterials.2013.04.062. Epub 2013 May 24.

PMID:
23706689
3.

IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.

Yu DH, Liu YR, Luan X, Liu HJ, Gao YG, Wu H, Fang C, Chen HZ.

Bioconjug Chem. 2015 Aug 19;26(8):1702-12. doi: 10.1021/acs.bioconjchem.5b00283. Epub 2015 Jun 26.

PMID:
26076081
4.

Delta-like ligand 4-targeted nanomedicine for antiangiogenic cancer therapy.

Liu YR, Guan YY, Luan X, Lu Q, Wang C, Liu HJ, Gao YG, Yang SC, Dong X, Chen HZ, Fang C.

Biomaterials. 2015 Feb;42:161-71. doi: 10.1016/j.biomaterials.2014.11.039. Epub 2014 Dec 16.

PMID:
25542804
5.

Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.

Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X.

Biomaterials. 2011 Dec;32(35):9457-69. doi: 10.1016/j.biomaterials.2011.08.055. Epub 2011 Sep 10.

PMID:
21911250
6.

CGKRK-modified nanoparticles for dual-targeting drug delivery to tumor cells and angiogenic blood vessels.

Hu Q, Gao X, Kang T, Feng X, Jiang D, Tu Y, Song Q, Yao L, Jiang X, Chen H, Chen J.

Biomaterials. 2013 Dec;34(37):9496-508. doi: 10.1016/j.biomaterials.2013.09.001. Epub 2013 Sep 17.

PMID:
24054848
7.

PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.

Gu G, Hu Q, Feng X, Gao X, Menglin J, Kang T, Jiang D, Song Q, Chen H, Chen J.

Biomaterials. 2014 Sep;35(28):8215-26. doi: 10.1016/j.biomaterials.2014.06.022. Epub 2014 Jun 25.

PMID:
24974009
8.

"OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.

Xiao K, Li Y, Lee JS, Gonik AM, Dong T, Fung G, Sanchez E, Xing L, Cheng HR, Luo J, Lam KS.

Cancer Res. 2012 Apr 15;72(8):2100-10. doi: 10.1158/0008-5472.CAN-11-3883. Epub 2012 Mar 6.

9.

Multi-targeting Peptide-Functionalized Nanoparticles Recognized Vasculogenic Mimicry, Tumor Neovasculature, and Glioma Cells for Enhanced Anti-glioma Therapy.

Feng X, Yao J, Gao X, Jing Y, Kang T, Jiang D, Jiang T, Feng J, Zhu Q, Jiang X, Chen J.

ACS Appl Mater Interfaces. 2015 Dec 23;7(50):27885-99. doi: 10.1021/acsami.5b09934. Epub 2015 Dec 14.

PMID:
26619329
10.

Mammary-Derived Growth Inhibitor Targeting Peptide-Modified PEG-PLA Nanoparticles for Enhanced Targeted Glioblastoma Therapy.

Feng X, Gao X, Kang T, Jiang D, Yao J, Jing Y, Song Q, Jiang X, Liang J, Chen J.

Bioconjug Chem. 2015 Aug 19;26(8):1850-61. doi: 10.1021/acs.bioconjchem.5b00379. Epub 2015 Aug 11.

PMID:
26222392
11.

Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.

Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.

Int J Pharm. 2010 Dec 15;402(1-2):238-47. doi: 10.1016/j.ijpharm.2010.10.005. Epub 2010 Oct 8.

PMID:
20934500
12.

Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.

Mishra GP, Nguyen D, Alani AW.

Mol Pharm. 2013 May 6;10(5):2071-8. doi: 10.1021/mp400122m. Epub 2013 Apr 16.

PMID:
23590802
13.

Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.

Zhan C, Gu B, Xie C, Li J, Liu Y, Lu W.

J Control Release. 2010 Apr 2;143(1):136-42. doi: 10.1016/j.jconrel.2009.12.020. Epub 2010 Jan 7.

PMID:
20056123
14.

Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles.

Jiang X, Xin H, Gu J, Du F, Feng C, Xie Y, Fang X.

J Pharm Sci. 2014 May;103(5):1487-96. doi: 10.1002/jps.23928. Epub 2014 Mar 11.

PMID:
24619482
15.

Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology.

Huang X, Zhang Y, Yin G, Pu X, Liao X, Huang Z, Chen X, Yao Y.

J Mater Sci Mater Med. 2015 Feb;26(2):95. doi: 10.1007/s10856-015-5447-x. Epub 2015 Feb 4.

PMID:
25649516
16.

PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.

Jiang X, Xin H, Sha X, Gu J, Jiang Y, Law K, Chen Y, Chen L, Wang X, Fang X.

Int J Pharm. 2011 Nov 28;420(2):385-94. doi: 10.1016/j.ijpharm.2011.08.052. Epub 2011 Sep 6.

PMID:
21920419
17.

Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.

Lu J, Chuan X, Zhang H, Dai W, Wang X, Wang X, Zhang Q.

Int J Pharm. 2014 Aug 25;471(1-2):525-35. doi: 10.1016/j.ijpharm.2014.05.032. Epub 2014 May 22.

PMID:
24858391
18.

Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.

Koo H, Min KH, Lee SC, Park JH, Park K, Jeong SY, Choi K, Kwon IC, Kim K.

J Control Release. 2013 Dec 28;172(3):823-31. doi: 10.1016/j.jconrel.2013.08.297. Epub 2013 Sep 11.

PMID:
24035978
19.

Formulation and evaluation of paclitaxel-loaded polymeric nanoparticles composed of polyethylene glycol and polylactic acid block copolymer.

Araki T, Kono Y, Ogawara K, Watanabe T, Ono T, Kimura T, Higaki K.

Biol Pharm Bull. 2012;35(8):1306-13.

20.

Development and evaluation of a novel TPGS-mediated paclitaxel-loaded PLGA-mPEG nanoparticle for the treatment of ovarian cancer.

Lv W, Cheng L, Li B.

Chem Pharm Bull (Tokyo). 2015;63(2):68-74. doi: 10.1248/cpb.c14-00423. Epub 2014 Nov 29.

Supplemental Content

Support Center